Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
- PMID: 21502239
- DOI: 10.1542/peds.2010-1722J
Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
Abstract
The Clinical Immunization Safety Assessment (CISA) Network is a collaboration between the Centers for Disease Control and Prevention (CDC) and 6 academic medical centers to provide support for immunization safety assessment and research. The CISA Network was established by the CDC in 2001 with 4 primary goals: (1) develop research protocols for clinical evaluation, diagnosis, and management of adverse events following immunization (AEFI); (2) improve the understanding of AEFI at the individual level, including determining possible genetic and other risk factors for predisposed people and subpopulations at high risk; (3) develop evidence-based algorithms for vaccination of people at risk of serious AEFI; and (4) serve as subject-matter experts for clinical vaccine-safety inquiries. CISA Network investigators bring in-depth clinical, pathophysiologic, and epidemiologic expertise to assessing causal relationships between vaccines and adverse events and to understanding the pathogenesis of AEFI. CISA Network researchers conduct expert reviews of clinically significant adverse events and determine the validity of the recorded diagnoses on the basis of clinical and laboratory criteria. They also conduct special studies to investigate the possible pathogenesis of adverse events, assess relationships between vaccines and adverse events, and maintain a centralized repository for clinical specimens. The CISA Network provides specific clinical guidance to both health care providers who administer vaccines and those who evaluate and treat patients with possible AEFI. The CISA Network plays an important role in providing critical immunization-safety data and expertise to inform vaccine policy-makers. The CISA Network serves as a unique resource for vaccine-safety monitoring efforts conducted at the CDC.
Similar articles
-
Clinical assessment of serious adverse events in children receiving 2009 H1N1 vaccination.Pediatr Infect Dis J. 2013 Feb;32(2):163-8. doi: 10.1097/INF.0b013e318271b90a. Pediatr Infect Dis J. 2013. PMID: 23334340
-
The Vaccine Safety Datalink: a model for monitoring immunization safety.Pediatrics. 2011 May;127 Suppl 1:S45-53. doi: 10.1542/peds.2010-1722H. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502240 Review.
-
[Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].Med Trop (Mars). 2009 Aug;69(4):320-1. Med Trop (Mars). 2009. PMID: 19725376 French.
-
Safety monitoring in vaccine development and immunization.Acta Paediatr Taiwan. 2006 Jan-Feb;47(1):7-13. Acta Paediatr Taiwan. 2006. PMID: 17016963 Review.
-
The Vaccine Safety Datalink project.Pharmacoepidemiol Drug Saf. 2001 Aug-Sep;10(5):403-6. doi: 10.1002/pds.613. Pharmacoepidemiol Drug Saf. 2001. PMID: 11802585
Cited by
-
Observational Study of Patients Hospitalized With Neurologic Events After SARS-CoV-2 Vaccination, December 2020-June 2021.Neurol Clin Pract. 2023 Aug;13(4):e200166. doi: 10.1212/CPJ.0000000000200166. Epub 2023 May 25. Neurol Clin Pract. 2023. PMID: 37251368
-
Advancing the Science of Vaccine Safety During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond: Launching an International Network of Special Immunization Services.Clin Infect Dis. 2022 Aug 15;75(Suppl 1):S11-S17. doi: 10.1093/cid/ciac407. Clin Infect Dis. 2022. PMID: 35680552 Free PMC article.
-
A review of vaccine effects on women in light of the COVID-19 pandemic.Taiwan J Obstet Gynecol. 2020 Nov;59(6):812-820. doi: 10.1016/j.tjog.2020.09.006. Epub 2020 Sep 11. Taiwan J Obstet Gynecol. 2020. PMID: 33218394 Free PMC article. Review.
-
Authors' reply: Safety of Human Papillomavirus Vaccines.Drug Saf. 2018 May;41(5):541-543. doi: 10.1007/s40264-018-0655-1. Drug Saf. 2018. PMID: 29582391 No abstract available.
-
T-cell receptor excision circle levels and safety of paediatric immunization: A population-based self-controlled case series analysis.Hum Vaccin Immunother. 2018 Jun 3;14(6):1378-1391. doi: 10.1080/21645515.2018.1433971. Epub 2018 Feb 26. Hum Vaccin Immunother. 2018. PMID: 29420131 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical